前立腺肥大症に対するSH 582の使用経験
スポンサーリンク
概要
- 論文の詳細を見る
20 patients (aged 56-80) with prostatic hypertrophy received intramuscular injection of SH 582 over a period of 1 to 5 months; the weekly dosage was 300 mg which was divided into one or three doses. SH 582 was clinically found effective for prostatism. It seems that the preparation is worthy of trial in patients who are unable or unwilling to receive surgical procedure.
- 泌尿器科紀要刊行会の論文
泌尿器科紀要刊行会 | 論文
- MVAC療法後の転移性尿路上皮癌に対するGemcitabine, Docetaxel, Carboplatin併用化学療法の検討
- Grade 3 Ta-1表在性膀胱癌に対する膀胱温存治療
- 腹腔鏡下に摘出した後腹膜神経線維腫の1例
- 移植腎生検による腎内動脈瘤破裂の1例
- Modified M-VAC療法後に残存腫瘍切除を施行した進行尿路上皮癌患者の治療成績